Are Things Looking Up For 2seventy bio Inc (NASDAQ: TSVT)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of 2seventy bio Inc is $297.08M. A total of 1.25 million shares were traded on the day, compared to an average of 1.47M shares.

In the most recent transaction, Casdin Capital, LLC bought 40,000 shares of TSVT for 5.10 per share on Mar 26 ’24. After the transaction, the Director now owns 2,000,000 company shares. In a previous transaction on Mar 25 ’24, Casdin Capital, LLC bought 330,000 shares at 5.07 per share. TSVT shares that Director owns now total 1,960,000.

Among the insiders who bought shares, Casdin Capital, LLC acquired of 147,377 shares on Mar 22 ’24 at a per-share price of $5.12. This resulted in the Director holding 1,630,000 shares of TSVT after the transaction. In another insider transaction, Casdin Capital, LLC bought 300,000 shares at $4.90 per share on Mar 21 ’24. Company shares held by the Director now total 1,482,623.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TSVT has a high of $12.69 and a low of $1.53.

As of this writing, TSVT has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.26 per share and a lower estimate of -$0.95. The company reported an EPS of -$1.4 in the last quarter, which was -35.90% lower than expectations of -$1.03.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TSVT’s latest balance sheet shows that the firm has $265.06M in Cash & Short Term Investments as of fiscal 2021. There were $282.21M in debt and $98.39M in liabilities at the time. Its Book Value Per Share was $5.04, while its Total Shareholder’s Equity was $359.82M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TSVT is Buy with a score of 3.57.

Most Popular

Related Posts